This $993,283 Project Grant award from the Defense Health Agency's Military Medical Research and Development program (CFDA 12.420) supports advanced biomedical research at the University of California, San Francisco (UCSF) aimed at transforming healthcare for military service members, veterans, and the broader public. The 2-year award, effective from September 1, 2025 to August 31, 2027, will fund proteomic research to investigate determinants and components of disease progression in multiple...
The federal Project Grant award of $1,008,313 was provided by the Defense Health Agency under the Military Medical Research and Development (CFDA 12.420) program. This award supports advanced biomedical research aimed at transforming healthcare for military service members, veterans, and the broader public. The award was granted to The Regents of the University of California, San Francisco (UCSF), a prominent academic medical center and research institution, to conduct research on melanoma....
This federal Project Grant award of $1,041,595.00 was provided by the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420) to The Regents of the University of California, San Francisco (UCSF) on September 1, 2024. The award supports advanced biomedical research aimed at transforming healthcare for military service members, veterans, and the broader public. Specifically, this 3-year Melanoma Research Program Team Science Award will fund innovative and...
This $300,000 Project Grant award was provided by the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420) to The Regents of the University of California, San Francisco (UCSF). The award is intended to support research focused on "Identifying Regulators of Extrafollicular Plasma Cell Differentiation" over the July 2024 to July 2026 performance period. As a leading academic medical center, UCSF will leverage its expertise in biomedical research...
The Defense Health Agency awarded a $1,453,500.00 Project Grant to The Regents of the University of California, San Francisco (UCSF) under the Military Medical Research and Development program (CFDA 12.420). This 3-year grant, commencing on June 20, 2023, will support UCSF's research to profile and eliminate tumor subclones resistant to radioligand therapy. Through this project, UCSF aims to transform health care for Service Members and the American public by developing innovative and...
This Project Grant award of $2,377,839.00 from the Defense Health Agency's Military Medical Research and Development program (CFDA 12.420) is funding evidence-based research to predict cardiovascular risk in immune-mediated inflammatory diseases. The grant was awarded on June 1, 2025 to The Regents of the University of California, San Francisco (UCSF), a leading academic medical center and research institution. Over the performance period of June 1, 2025 to May 31, 2029, this funding will...
This federal Project Grant award of $997,060 from the Department of Defense's Military Medical Research and Development program (CFDA 12.420) supports research at the University of California, San Francisco (UCSF) to develop a new understanding of selective neuron vulnerability and neuroprotection in progressive multiple sclerosis. The award has a performance period from September 15, 2024 to September 14, 2027. As a leading academic medical center and research institution, UCSF will leverage...
The federal Project Grant award, valued at $1,312,000.00 and awarded by the Defense Health Agency under the Military Medical Research and Development (CFDA 12.420) program, will support research strategies to upregulate and image Nectin4 to enhance Nectin4-targeted therapies in bladder cancer. The research, to be conducted by The Regents of the University of California, San Francisco (UCSF) from August 1, 2025 to July 31, 2029, aims to transform healthcare for military service members, veterans,...
This federal Project Grant award from the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420) provides $328,000.00 in funding to The Regents of the University of California, San Francisco (UCSF) to investigate intracalvarial drug delivery strategies into skull bone marrow to create an antitumoral myeloid cell immune response to glioblastoma. The award period is from July 1, 2025 to June 30, 2027. As a leading academic medical center and research...
The University of California, San Francisco (UCSF) has been awarded a $726,745 Project Grant from the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420). The grant, awarded on June 1, 2024, will support a 3-year research project to investigate "DISSECTING RAS GAP SPECIFICITY IN THE PERIPHERAL NERVOUS SYSTEM". The research aims to advance the understanding of key cellular signaling mechanisms involved in the peripheral nervous system, with...